7,16-Dichlorodinaphtho[2,3-a:2',3'-h]phenazine-5,9,14,18(6H,15H)-tetraone

Catalog No. :
ACNRYD239
CAS No. :
130-20-1
Molecular Formula :
C28H12Cl2N2O4
Molecular Weight :
511.32

IUPAC Name:7,16-dichloro-6,15-dihydrodinaphtho[2,3-a:2',3'-h]phenazine-5,9,14,18-tetraone

7,16-Dichlorodinaphtho[2,3-a:2',3'-h]phenazine-5,9,14,18(6H,15H)-tetraone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$69.00Login to see priceInquiryInquiry
5g95%$164.00Login to see priceInquiryInquiry
25g95%$590.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7,16-Dichlorodinaphtho[2,3-a:2',3'-h]phenazine-5,9,14,18(6H,15H)-tetraone
IUPAC Name7,16-dichloro-6,15-dihydrodinaphtho[2,3-a:2',3'-h]phenazine-5,9,14,18-tetraone
MDL No.MFCD00046965
Molecular FormulaC28H12Cl2N2O4
Molecular Weight511.32
SMILESClC1=CC2=C(C(=O)C3=C(C=CC=C3)C2=O)C2=C1NC1=C(N2)C(Cl)=CC2=C1C(=O)C1=C(C=CC=C1)C2=O
InChI KeyUGCDBQWJXSAYIL-UHFFFAOYSA-N
SynonymNihonthrene Brilliant Blue RCL | Palanthrene Blue BCA | 3, 3'-Dichloroindanthrone | CI 69825 | Nihonthrene Blue BC | Vat Fast Blue BCS | D&C Blue No. 9 | Fenan Blue BCS | Monolite Fast Blue 2RVSA | Solanthrene Blue B | 7,16-Dichloro-6,15-dihydroanthrazine
CAS No.130-20-1
PubChem CID8532

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACNRYD239 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNRYD239 route product structure diagram
    ACNRYD239130-20-1
Inquiry

2. ACNRYD239 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNRYD239 route product structure diagram
    ACNRYD239130-20-1
Inquiry

Comments (0)